{
    "eid": "2-s2.0-85045737757",
    "title": "Current challenges and opportunities in treating glioblastomas",
    "cover-date": "2018-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [],
    "authors": [
        "Andrea Shergalis",
        "Armand Bankhead",
        "Urarika Luesakul",
        "Nongnuj Muangsin",
        "Nouri Neamati"
    ],
    "citedby-count": 430,
    "ref-count": 266,
    "ref-list": [
        "Recent progress in cancer thermal therapy using gold nanoparticles",
        "Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases",
        "Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux",
        "Phase II trial of dovitinib in recurrent glioblastoma",
        "Nolan J, et al. (2015)miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients",
        "Alvarez-Buylla A, and Parada LF (2009)Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model",
        "A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia",
        "Nanoparticles in the clinic",
        "Cancer-related axonogenesis and neurogenesis in prostate cancer",
        "PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response",
        "Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity",
        "Characteristics of compounds that cross the blood-brain barrier",
        "From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery",
        "The blood-brain barrier and oncology: New insights into function and modulation",
        "Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma",
        "Estrogen receptor beta (ER beta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm",
        "Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles",
        "Gene knockdown of CENPA reduces sphere forming ability and stemness of glioblastoma initiating cells",
        "Patient-derived xenografts undergo mouse-specific tumor evolution",
        "Roles for Nkx3.1 in prostate development and cancer",
        "Blood brain barrier: A challenge for effectual therapy of brain tumors",
        "The somatic genomic landscape of glioblastoma",
        "Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy",
        "Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin",
        "Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: Crossing the blood-brain barrier divide",
        "Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer",
        "Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: Meta-analysis",
        "Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor",
        "Addressing brain tumors with targeted gold nanoparticles: A new gold standard for hydrophobic drug delivery?",
        "Multifunctional nanoparticles for brain tumor imaging and therapy",
        "Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma",
        "Granzymes and perforin in solid organ transplant rejection",
        "Role of amino-acid-transport and countertransport in nutrition and metabolism",
        "A Phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma",
        "Granzymes in cancer and immunity",
        "Structural studies revealed active site distortions of human furin by a small molecule inhibitor",
        "Targeted proteomics to assess the response to anti-angiogenic treatment in human glioblastoma (GBM)",
        "Molecular heterogeneity of glioblastomas: Does location matter?",
        "Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP",
        "What is wrong with clinical proteomics?",
        "Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers",
        "Final results from the AXIG trial: A randomized Phase II clinical trial investigating axitinib alone or in combination with CCNU in patients with recurrent glioblastoma",
        "Blood-brain-barrier transcytosis of insulin in developing rabbits",
        "Sunitinib stimulates expression of VEGFC by tumor cells and promotes lymphangiogenesis in clear cell renal cell carcinomas",
        "Junctional adhesion molecules (JAMs): More molecules with dual functions?",
        "Adjuvant effects of a sequence-engineered mRNA vaccine: Translational profiling demonstrates similar human and murine innate response",
        "Temozolomide nanoparticles for targeted glioblastoma therapy",
        "Elevation of urinary 2-hydroxyglutarate in IDH-mutant glioma",
        "Elov16 is a poor prognostic predictor in breast cancer",
        "Synthesis of glycosyl derivatives as dopamine prodrugs: Interaction with glucose carrier GLUT-1",
        "Expression analysis of genes involved in the RB/E2F pathway in astrocytic tumors",
        "ABC transporters as mediators of drug resistance and contributors to cancer cell biology",
        "EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics",
        "Mutant p53: One name, many proteins",
        "Gene expression profiling of gliomas strongly predicts survival",
        "Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier",
        "Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma",
        "Insulin fragments as a carrier for peptide delivery across the blood-brain barrier",
        "Semaphorin-plexin signalling genes associated with human breast tumourigenesis",
        "Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)",
        "Antibody-drug conjugates in glioblastoma therapy: The right drugs to the right cells",
        "Phase II study of bevacizumab and vorinostat for patients with recurrent World Health Organization grade 4 malignant glioma",
        "Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery",
        "A cell-surface membrane protein signature for glioblastoma",
        "A randomized trial of bevacizumab for newly diagnosed glioblastoma",
        "HEB silencing induces anti-proliferative effects on U87MG cells cultured as neurospheres and monolayers",
        "L-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4",
        "New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group Phase I and II clinical trials",
        "Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells",
        "Phase 2 study of aldoxorubicin in relapsed glioblastoma",
        "TPX2 promotes glioma cell proliferation and invasion via activation of the AKT signaling pathway",
        "Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics",
        "Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers",
        "Mediators of vascular remodelling co-opted for sequential steps in lung metastasis",
        "Annexin II: A mediator of the plasmin/plasminogen activator system",
        "Integrating cancer genomics and proteomics in the post-genome era",
        "Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines",
        "Protein-protein and peptide-protein interactions of NudE-Like 1 (Ndel1): A protein involved in schizophrenia",
        "A novel human prostate-specific, androgen-regulated homeobox gene (NKX3. 1) that maps to 8p21, a region frequently deleted in prostate cancer",
        "MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C",
        "Discovery of clinical development candidate GDC-0084, a brain penetrant inhibitor of PI3K and mTOR",
        "MGMT gene silencing and benefit from temozolomide in glioblastoma",
        "Active transport of fentanyl by the blood-brain barrier",
        "Aberrant DNA methylation profiles in the premature aging disorders Hutchinson-Gilford Progeria and Werner Syndrome",
        "TCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma",
        "Regulation of the actin cytoskeleton by the Ndel1-Tara complex is critical for cell migration",
        "Flavin-dependent sulfhydryl oxidases in protein disulfide bond formation",
        "Follicular dendritic cell secreted protein FDC-SP controls IgA production",
        "Identification of prostate cancer lncRNAs by RNA-seq",
        "A novel NF-kappa B binding site controls human granzyme B gene transcription",
        "Oncogenic EGFR signaling networks in glioma",
        "In vivo models of primary brain tumors: Pitfalls and perspectives",
        "Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo",
        "Molecular classification and survival prediction in human gliomas based on proteome analysis",
        "The proprotein convertase furin in tumour progression",
        "Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab",
        "Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion",
        "Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas",
        "NK3 homeobox 1 (NKX3. 1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion",
        "HSP47 promotes glioblastoma stemlike cell survival by modulating tumor microenvironment extracellular matrix through TGF-beta pathway",
        "Enhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticles",
        "Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo",
        "Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma",
        "Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin/transferrin receptor complex",
        "Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL",
        "Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases",
        "Two decades of new drug development for central nervous system disorders",
        "A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival",
        "Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM",
        "Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma",
        "Can the pharmaceutical industry reduce attrition rates?",
        "Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers",
        "Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: Replication and immunotherapeutic effects in recurrent malignant glioma",
        "Ultrasound treatment of neurological diseases-current and emerging applications",
        "IKK\u03b1, IKK\u03b2, and NEMO/IKK\u03b3 are each required for the NF-\u03baB-mediated inflammatory response program",
        "Brain-specific delivery of dopamine mediated by N,N-dimethyl amino group for the treatment of Parkinson\u2019s disease",
        "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings",
        "Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells",
        "Nanoparticle surface charges alter blood-brain barrier integrity and permeability",
        "Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing",
        "Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation",
        "Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma",
        "Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme",
        "One mouse, one patient paradigm: New avatars of personalized cancer therapy",
        "Positional scanning identifies the molecular determinants of a high affinity multi-leucine inhibitor for furin and PACE4",
        "Vascular endothelial growth factor\u2010C\u2010mediated lymphangiogenesis promotes tumour metastasis",
        "Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity",
        "EGFR tyrosine kinase domain mutations in human gliomas",
        "Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma",
        "FDC-SP, a novel secreted protein expressed by follicular dendritic cells",
        "Iro/IRX transcription factors negatively regulate Dpp/TGF-beta pathway activity during intestinal tumorigenesis",
        "Proteomics-based analysis of invasion-related proteins in malignant gliomas",
        "Elovl6: A new player in fatty acid metabolism and insulin sensitivity",
        "Annexin 2A sustains glioblastoma cell dissemination and proliferation",
        "Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors",
        "Inhibition of furin-mediated processing results in suppression of astrocytoma cell growth and invasiveness",
        "Transcription elongation factors represent in vivo cancer dependencies in glioblastoma",
        "Current trends in mouse models of glioblastoma",
        "Tailoring particle size of mesoporous silica nanosystem to antagonize glioblastoma and overcome blood-brain barrier",
        "Restricted transport of anti\u2010transferrin receptor antibody (OX26) through the blood-brain barrier in the rat",
        "High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats",
        "A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling",
        "Stem cell-related \u201cSelf-Renewal\u201d signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma",
        "Pharos: Collating protein information to shed light on the druggable genome",
        "ER\u03b2 sensitizes NSCLC to chemotherapy by regulating DNA damage response",
        "The \u201con-off\u201d phenomenon in Parkinson\u2019s disease: Relation to levodopa absorption and transport",
        "Development of orally active inhibitors of protein and cellular fucosylation",
        "Blood-brain barrier: Penetration of morphine, codeine, heroin, and methadone after carotid injection",
        "Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na+/K+-ATPase",
        "Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets",
        "Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours",
        "Insulin induces a transcriptional activation of epiregulin, HB-EGF and amphiregulin, by a PI3K-dependent mechanism: Identification of a specific insulin-responsive promoter element",
        "AP-2 alpha and AP-2 gamma regulate tumor progression via specific genetic programs",
        "CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013",
        "Lack of constitutively active DNA repair sensitizes glioblastomas to Akt inhibition and induces synthetic lethality with radiation treatment in a p53-dependent manner",
        "NF1 loss disrupts Schwann cell-axonal interactions: A novel role for semaphorin 4F",
        "Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G(2) cell cycle arrest",
        "Network signatures of survival in glioblastoma multiforme",
        "Non-stem cell origin for oligodendroglioma",
        "Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(Butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants",
        "Use of proteomic patterns in serum to identify ovarian cancer",
        "Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe",
        "A protease storm cleaves a cell-cell adhesion molecule in cancer: Multiple proteases converge to regulate ptpmu in glioma cells",
        "Macromolecular permeability across the blood-nerve and blood-brain barriers",
        "LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions",
        "Cytotoxic T cells and granzyme B associated with improved colorectal cancer survival in a prospective cohort of older women",
        "All in the mind? Brain-targeting chemical delivery system of 17\u03b2-estradiol (Estredox) produces significant uterotrophic side effect",
        "Phase II trial of temozolomide plus O(6)-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma",
        "CNS drug design: Balancing physicochemical properties for optimal brain exposure",
        "CNS physicochemical property space shaped by a diverse set of molecules with experimentally determined exposure in the mouse brain",
        "Prodrug approaches for CNS delivery",
        "R: A Language and Environment for Statistical Computing",
        "Clinical trial end points for high-grade glioma: The evolving landscape",
        "A Phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma",
        "Three-dimensional pharmacophore design and biochemical screening identifies substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction",
        "Advances in the molecular genetics of gliomas-implications for classification and therapy",
        "Gene expression profiling and genetic markers in glioblastoma survival",
        "Epiregulin: Roles in normal physiology and cancer",
        "The hedgehog signal transduction network",
        "Effect of alternative temozolomide schedules on glioblastoma O6-methylguanine-DNA methyltransferase activity and survival",
        "Granzyme B-induced apoptosis in cancer cells and its regulation",
        "Roles of metalloproteases in metastatic niche",
        "Advanced drug delivery systems: Nanotechnology of health design A review",
        "A comprehensive map of molecular drug targets",
        "Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases",
        "Selective estrogen receptor \u03b2 agonist LY500307 as a novel therapeutic agent for glioblastoma",
        "Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction",
        "Phase I trial of dovitinib (TKI258) in recurrent glioblastoma",
        "Animal models in glioblastoma: Use in biology and developing therapeutic strategies",
        "Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation",
        "Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma",
        "Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas",
        "Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications",
        "Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein family",
        "Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme",
        "A Phase l study of a tumor-targeted systemic nanodelivery system, SGT-94, in genitourinary cancers",
        "Cancer statistics, 2016",
        "In vivo models of brain tumors: Roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies",
        "The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers",
        "Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis",
        "Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells",
        "Bevacizumab and CPT-11 in the treatment of relapsed malignant glioma",
        "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma",
        "Proteomic analysis of glioma chemoresistance",
        "Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer",
        "Rindopepimut: A promising immunotherapeutic for the treatment of glioblastoma multiforme",
        "ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1",
        "Synthetic sickness or lethality points at candidate combination therapy targets in glioblastoma",
        "Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): A randomised controlled Phase 2 trial",
        "P53 short peptide (P53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-\u03b1 factor/cytokine expression",
        "Novel transcriptional regulation of VEGF in inflammatory processes",
        "Mir-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC",
        "Complex molecular regulation of tyrosine hydroxylase",
        "Low expression of microRNA-1908 predicts a poor prognosis for patients with ovarian cancer",
        "The cell surface membrane proteins Cdo and Boc are components and targets of the hedgehog signaling pathway and feedback network in mice",
        "HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells",
        "Relapsed glioblastoma: Treatment strategies for initial and subsequent recurrences",
        "Recruitment of katanin p60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration",
        "A two-part safety and exploratory efficacy randomized double-blind, placebo-controlled study of a 1:1 ratio of the cannabinoids cannabidiol and delta-9-tetrahydrocannabinol (CBD:THC) plus dose-intense temozolomide in patients with recurrent glioblastoma multiforme (GBM)",
        "A Phase IB/II, open-label, multicenter study of capmatinib (INC280) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma",
        "Overcoming the blood-brain tumor barrier for effective glioblastoma treatment",
        "Proteomic characterization of nipple aspirate fluid: Identification of potential biomarkers of breast cancer",
        "Cutting edge: ERK1 mediates the autocrine positive feedback loop of TGF-\u03b2 and furin in glioma-initiating cells",
        "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1",
        "Nanoparticles for hyperthermic therapy: Synthesis strategies and applications in glioblastoma",
        "Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: Electron microscopist\u2019s view",
        "Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis",
        "Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties",
        "C4orf7 contributes to ovarian cancer metastasis by promoting cancer cell migration and invasion",
        "Scopine as a novel brain-targeting moiety enhances the brain uptake of chlorambucil",
        "Down-regulation of human granzyme B expression by glucocorticoids-Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter",
        "Synthetic lethality-based targets for discovery of new cancer therapeutics",
        "The retinoblastoma protein and cell cycle control",
        "Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): A randomised, double-blind, international phase 3 trial",
        "Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American brain tumor consortium trial 04-02",
        "A first-in-human Phase 1 study to evaluate the brain-penetrant PI3K/mTOR inhibitor GDC-0084 in patients with progressive or recurrent high-grade glioma",
        "Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor",
        "Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies",
        "Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2",
        "Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection",
        "B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway",
        "Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines",
        "Development of proteomic patterns for detecting lung cancer",
        "IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype",
        "The human glioblastoma cell culture resource: validated cell models representing all molecular subtypes",
        "Cathepsin L is involved in X-ray-induced invasion and migration of human glioma U251 cells",
        "Small cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2",
        "Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas",
        "Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence",
        "Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer",
        "SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme",
        "Enzyme-mediated hydrolytic activation of prodrugs",
        "Transforming properties of 8p11-12 amplified genes in human breast cancer",
        "Identification of differential splicing genes in gliomas using exon expression profiling",
        "Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme",
        "EZH2 overexpression is associated with poor prognosis in patients with glioma",
        "Concurrent expression of VEGF-C and neuropilin-2 is correlated with poor prognosis in glioblastoma",
        "LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth",
        "Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma",
        "LITAF is a potential tumor suppressor in pancreatic cancer",
        "CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency",
        "Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis",
        "Lipopolysaccharide-induced tumor necrosis factor-\u03b1 factor enhances inflammation and is associated with cancer",
        "Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling"
    ],
    "affiliation": [
        {
            "affiliation-city": "Ann Arbor",
            "@id": "60025778",
            "affilname": "University of Michigan, Ann Arbor",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025778",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Cancer Institute"
    ]
}